Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products.
$2.29-5.19%
报价 2026-11-09
市值
$2.3M
EV
$2.5M
PE (TTM)
0.5x
预期 PE
–
52 周区间距高点 -89.7%
$1.78$22.12
筛选结果
pipeline · 2026-11-09Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Diagnostics & Research| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| MBAICheck-Cap Ltd. Ordinary Share | $2.3M | -5.2% | – | 0% | 0.5x | 0.6x | – | |
| BNGOBionano Genomics, Inc. | $13.7M | +0.9% | +13.0% | 47.5% | – | – | – | |
| BNRBurning Rock Biotech Limited | $13.1M | -7.7% | – | 74.6% | – | – | – | |
| INBSIntelligent Bio Solutions Inc. | $7.6M | +16.2% | -44.1% | 27.7% | – | – | – | |
| NDRAENDRA Life Sciences Inc. | $7.3M | +2.3% | 0.0% | 0% | – | – | – | |
| ADVBAdvanced Biomed Inc. Common Stock | $3.4M | +3.5% | – | -3,856.4% | 6.5x | – | – | |
| VNRXVolitionRx Limited | $2.4M | +2.1% | +277.8% | 89.6% | – | – | – | |
| BGLCBioNexus Gene Lab Corp. | $2.2M | +7.5% | – | 14.8% | – | – | – | |
| ISPCiSpecimen Inc. | $2M | -3.0% | +204.8% | -29.6% | – | – | – | |
| 同行中位数 | – | – | +13.0% | 21.2% | 6.5x | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。